In this article, we explore critical factors in the development of gene therapies, including trial management, accelerated approval pathways, and companion diagnostic development and its coordination with therapeutic development.
The term "value" may be thought of as "benefit" which, in turn, triggers a discussion on the opportunity cost of other forgone benefits. New cost-effectiveness modeling methods are required to accommodate the novel sources of value.
Despite efforts to accelerate FDA evaluation of drug safety and efficacy, uptake of many new therapies has been much slower than expected. Why the lag?
In a new MedAd News feature article on the influence of value assessments, Precision Xtract’s Jacki Chou and Zac Stillerman provide their insights on the growing influence of ICER, and how manufacturers can be more proactive in shaping favorable assessments of their new treatments.
Precision experts Jeremy Schafer, Jacki Chou, and Harry G. Schiavi join other industry leaders in discussing the potential repercussions of the rule.
HHS’ proposed changes to Medicare Part D loosening government restrictions on 4 protected drug classes directly imperils those with HIV who have Medicare as their source of health coverage,
The Institute for Clinical and Economic Review (ICER) says it will create a series of so-called Unsupported Price Increase (UPI) reports that will examine whether price increases are justified.
The Precision Value & Health family of brands is now Precision AQ
Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life-changing medicines.
Our global offerings include:
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.
To find out more about our global services and our unified mission, empowering access to life-changing medicines for all, visit: Precision AQ
